Macroeconomic and pharma-specific indicators backed up Lilly's investment decision
Case study about how macroeconomic and pharma-specific indicators backed up Lilly's investment decision in Alzey, Germany
The case study explores the strategic rationale of the U.S. pharma company Eli Lilly choosing Alzey, Germany as a new production site by analysing macroeconomic and industry-specific ratios.
